Germany's Atlas Biolabs is now a certified service provider for Roche NimbleGen's SeqCap EZ enrichment to prepare genomic DNA for sequencing.
Atlas Biolabs will now be able to offer enrichment services using both Roche's SeqCap EZ Exome kit, as well as its recently launched SeqCap EZ Choice Libraries for enrichment of custom regions of interest in a single test tube. According to the company, the new technology is ideal for targeting disease-associated regions of the genome.
The Wellcome Trust Sanger Institute has released version 52 of COSMIC, the Catalogue of Somatic Mutations in Cancer. The new version includes the curation of four new genes and 16 new fusion pairs, and updates from the International Cancer Genome Consortium and the Cancer Genome Atlas. It also integrates data from the Genomics of Drug Sensitivity in Cancer, a collaborative project between the Sanger Institute and Massachusetts General Hospital. Additionally, 21 new genes have been added to the Cancer Gene Census.